Cutler Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Cutler Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,500	Closed	-$17K	–	5682
2017 Q3	$17K	Buy	10,500 +200	+2%	+$12.6K	﹤0.01%	3283
2017 Q2	$26K	Sell	10,300 -400	-4%	-$24K	﹤0.01%	3146
2017 Q1	$10K	Buy	+10,700	New	+$626K	﹤0.01%	4051
2016 Q4	–	Sell	-3,900	Closed	-$1K	–	7127
2016 Q3	$1K	Buy	+3,900	New	+$255K	﹤0.01%	6234

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cutler Group's PJP Position: Q1 2020 in Review

Cutler Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2020, closing a stake of 200 shares — an estimated $12K sold.

Cutler Group first reported a position in PJP in Q1 2016 and held it in 4 quarters. The position peaked at $127K in Q2 2016. 86 funds tracked by Wall St. Rank hold PJP as of Q1 2020.

Cutler Group reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
Cutler Group sold 200 Invesco Pharmaceuticals ETF shares in Q1 2020, an estimated $12K.
Cutler Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and held it in 4 quarters.
Cutler Group's Invesco Pharmaceuticals ETF position peaked at $127K in Q2 2016.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.